Applied Clinical Trials-04-01-2021

European Group on Ethics in Science and New Technologies issues cautious opinion on the use of gene editing amidst COVID vaccination controversy.

Behind-the-scenes look at vaccine development.

Click the title above for a link to open the Applied Clinical Trials April 2021 issue in an interactive PDF format.

Growing availability of RWD leads new drug development process.

How asking better questions and leveraging site databases can expand access to more patients.

Compression between phases to accelerate cycle time.

New BDO CRO Insights Report reveals high rate of CRA turnover and what organizations are doing to combat it.

Steven Bukvic, CEO of the ACROSS Global Alliance, speaks to Applied Clinical Trials about how it works to improve the clinical trial experience for smaller- and medium-sized sponsors.

FDA is reviewing the record of its accelerated approval program following recent withdrawals of certain key indications for several leading cancer therapies, based on the failure of post-approval studies to document extended benefits of treatment.

Identifying the ‘significant six’ areas of clinical study conduct to mitigate risk.

A new partnership, to be known as EP PerMed, aims to bring public and private sector interests together.